Publications for Austin Meng Guo austin_guo@nymc.edu
Chen, L., Joseph, G., Zhang, F. F., Nguyen, H., Jiang, H., Schwartzman, M. L., . . . Guo, A. M. (2016). 20-HETE contributes to ischemia-induced angiogenesis. Vascular Pharmacology, 83, 57-65. doi:10.1016/j.vph.2016.04.002
Borin, T. F., Zuccari, D. A., Jardim-Perassi, B. V., Ferreira, L. C., Iskander, A. S., Varma, N. R., Shankar, A., Guo, A. M., Scicli, G., & Arbab, A. S. (2014). HET0016, a selective inhibitor of 20-HETE synthesis, decreases pro-angiogenic factors and inhibits growth of triple negative breast cancer in mice. PloS One, 9(12), e116247. doi:10.1371/journal.pone.0116247
Chen, L., Ackerman, R., Saleh, M., Gotlinger, K. H., Kessler, M., Mendelowitz, L. G., Schwartzman, M. L., . . . Guo, A. M. (2014). 20-HETE regulates the angiogenic functions of human endothelial progenitor cells and contributes to angiogenesis in vivo. The Journal of Pharmacology and Experimental Therapeutics, 348(3), 442-451. doi:10.1124/jpet.113.210120
Zhao, H., Zhang, X., Chen, X., Li, Y., Ke, Z., Tang, T., . . . Guo, A. M. (2014). Isoliquiritigenin, a flavonoid from licorice, blocks M2 macrophage polarization in colitis-associated tumorigenesis through downregulating PGE and IL-6. Toxicology and Applied Pharmacology, 279(3), 311-321. doi:10.1016/j.taap.2014.07.001
Zheng, H., Li, Y., Wang, Y., Zhao, H., Zhang, J., Chai, H., . . . Guo, A. M. (2014). Downregulation of COX-2 and CYP 4A signaling by isoliquiritigenin inhibits human breast cancer metastasis through preventing anoikis resistance, migration and invasion. Toxicology and Applied Pharmacology, 280(1), 10-20. doi:10.1016/j.taap.2014.07.018
Issan, Y., Hochhauser, E., Guo, A., Gotlinger, K. H., Thompson, C. I., Abraham, N. G., . . . Schwartzman, M. L. (2013). Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia. Prostaglandins and Other Lipid Mediators, 100-101(1), 15-21. doi:10.1016/j.prostaglandins.2012.12.002
Li, Y., Zhao, H., Wang, Y., Zheng, H., Yu, W., Chai, H., . . .Guo, A. M.(2013). Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer. Toxicology and Applied Pharmacology, 272(1), 37-48. doi:10.1016/j.taap.2013.05.031
